Statement of Organization, Functions, and Delegations of Authority, 1446 [06-144]

Download as PDF cprice-sewell on PROD1PC66 with NOTICES 1446 Federal Register / Vol. 71, No. 5 / Monday, January 9, 2006 / Notices Agenda: To review and evaluate grant applications. Place: National Institutes of Health, Building 31, 31 Center Drive, Conference Room 10, Bethesda, MD 20892. Open: February 16, 2006, 8:30 a.m. to 9:30 a.m. Agenda: Continuation of the review of the Division’s scientific and planning activities. Place: National Institutes of Health, Building 31, 31 Center Drive, Conference Room 10, Bethesda, MD 20892. Contact Person: Brent B. Stanfield, PhD, Director, Division of Extramural Activities, National Institute of Diabetes and Digestive and Kidney Diseases, 6707 Democracy Blvd., Room 715, Bethesda, MD 20892. (301) 594– 8843. stanfieldb@extra.niddk.nih.gov. Name of Committee: National Diabetes and Digestive and Kidney Diseases Advisory Council, Digestive Diseases and Nutrition Subcommittee. Date: February 15–16, 2006. Open: February 15, 2006, 1 p.m. to 3 p.m. Agenda: To review the Division’s scientific and planning activities. Place: National Institutes of Health, Building 31, 31 Center Drive, Conference Room 9A22, Bethesda, MD 20892. Closed: February 15, 2006, 3:15 p.m. to 5:30 p.m. Agenda: To review and evaluate grant applications. Place: National Institutes of Health, Building 31, 31 Center Drive, Conference Room 9A22, Bethesda, MD 20892. Open: February 16, 2006, 8 a.m. to 9:30 a.m. Agenda: Continuation of the review of the Division’s scientific and planning activities. Place: National Institutes of Health, Building 31, 31 Center Drive, Conference Room 9A22, Bethesda, MD 20892. Contact Person: Brent B. Stanfield, PhD, Director of Extramural Activities, National Institute of Diabetes and Digestive and Kidney Diseases, 6707 Democracy Blvd., Room 715, Bethesda, MD 20892. (301) 594– 8843. stanfieldb@extra.niddk.nih.gov. Name of Committee: National Diabetes and Digestive and Kidney Diseases Advisory Council, Kidney, Urologic, and Hematologic Diseases Subcommittee. Date: February 15–16, 2006. Open: February 15, 2006, 1 p.m. to 5:30 p.m. Agenda: To review the Division’s scientific and planning activities. Place: National Institutes of Health, Building 31, 31 Center Drive, Conference Room, Bethesda, MD 20892. Closed: February 16, 2006, 8 a.m. to 9:30 a.m. Agenda: To review and evaluate grant applications. Place: National Institutes of Health, Building 31, 31 Center Drive, Conference Room 7, Bethesda, MD 20892. Contact Person: Brent B. Stanfield, PhD, Director, Division of Extramural Activities, National Institute of Diabetes and Digestive and Kidney Diseases, 6707 Democracy Blvd., Room 715, Bethesda, MD 20892. (301) 594– 8843. stanfieldb@extra.niddk.nih.gov. Any interested person may file written comments with the committee by forwarding VerDate Aug<31>2005 15:31 Jan 06, 2006 Jkt 208001 the statement to the Contact Person listed on this notice. The statement should include the name, address, telephone number and when applicable, the business or professional affiliation of the interested person. In the interest of security, NIH has instituted stringent procedures for entrance into the building by non-government employees. Persons without a government I.D. will need to show a photo I.D. and sign in at the security desk upon entering the building. Information is also available on the Institute’s/Center’s home page: https:// www.niddk.nih.gov/fund/divisions/DEA/ Council/coundesc.htm., where an agenda and any additional information for the meeting will be posted when available. (Catalogue of Federal Domestic Assistance Program Nos. 93.847, Diabetes, Endocrinology and Metabolic Research; 93.848, Digestive Diseases and Nutrition Research; 93.849, Kidney Diseases, Urology and Hematology Research, National Institutes of Health, HHS) Dated: December 29, 2005. Anna Snouffer, Acting Director, Office of Federal Advisory Committee Policy. [FR Doc. 06–143 Filed 1–6–06; 8:45 am] BILLING CODE 4140–01–M DEPARTMENT OF HEALTH AND HUMAN SERVICES collaboration and cooperation between the NIH and the surrounding community; (3) conducts and oversees studies, projects, and evaluations designed to address problems, questions, and issues of community concern and environmental impact; (4) ensures that NIH activities affecting the surrounding community involve community representation at all levels of design, review, and implementation; and (5) ensures effective communication and collaboration on policy and programs involving the surrounding community between the Office of the Director, NIH, and operating components of the NIH. (2) Delete the Office of Community Liaison (NAP, formerly HNAP) in its entirety. Delegations of Authority: All delegations and redelegations of authority to officers and employees of NIH that were in effect immediately prior to the effective date of this amendment and are consistent with this amendment shall continue in effect, pending further redelegation. Dated: November 4, 2005. Elias A. Zerhouni, Director, National Institutes of Health. [FR Doc. 06–144 Filed 1–6–06; 8:45 am] BILLING CODE 4140–01–M National Institutes of Health Statement of Organization, Functions, and Delegations of Authority DEPARTMENT OF HEALTH AND HUMAN SERVICES Part N, National Institutes of Health, of the Statement of Organization, Functions, and Delegations of Authority for the Department of Health and Human Services (HHS) (40 FR 22859, May 27, 1975, as amended most recently at 69 FR 64081, November 3, 2004, and redesignated from Part HN as part N at 60 FR 56606, November 9, 1995), is amended as set forth below to reflect the reorganization of the Office of the Director, NIH, by transferring the Office of Community Liaison from the Office of the Director (OD) to the Office of Communications and Public Liaison, OD. Section N–B, Organization and Functions, under the heading Office of the Director (NA, formerly HNA), is amended as follows: (1) Under the heading Office of Communications and Public Liaison (NA8, formerly HNA8) insert the following: Office of Community Liaison (NA85, formerly HNA85). (1) Advises the NIH Director on policies, programs, and issues involving the NIH and the surrounding community; (2) plans and directs activities to promote National Institutes of Health PO 00000 Frm 00041 Fmt 4703 Sfmt 4703 Statement of Organization, Functions, and Delegations of Authority Part N, National Institutes of Health, of the Statement of Organization, Functions, and Delegations of Authority for the Department of Health and Human Services (HHS) (40 FR 22859, May 27, 1975, as amended most recently at 70 FR 61146, October 20, 2005, and redesignated from Part HN as Part N at 60 FR 56606, November 9, 1995), is amended as set forth below to reflect the reorganization of the NIH Ethics Office. Section N-B, Organization and Functions, under the heading Office of the Director (NA, formerly HNA), is amended as follows: Replace the current section NAT (formerly HNAT) with the following: NIH Ethics Office (NAT, formerly HNAT). (1) Provides oversight and strategic direction of NIH activities relating to ethics policy, oversight, and operational activities; (2) develops and administers the NIH policies and procedures for implementing the Government-wide conflict of interest statutes and regulations, the HHS E:\FR\FM\09JAN1.SGM 09JAN1

Agencies

[Federal Register Volume 71, Number 5 (Monday, January 9, 2006)]
[Notices]
[Page 1446]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 06-144]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

National Institutes of Health


Statement of Organization, Functions, and Delegations of 
Authority

    Part N, National Institutes of Health, of the Statement of 
Organization, Functions, and Delegations of Authority for the 
Department of Health and Human Services (HHS) (40 FR 22859, May 27, 
1975, as amended most recently at 69 FR 64081, November 3, 2004, and 
redesignated from Part HN as part N at 60 FR 56606, November 9, 1995), 
is amended as set forth below to reflect the reorganization of the 
Office of the Director, NIH, by transferring the Office of Community 
Liaison from the Office of the Director (OD) to the Office of 
Communications and Public Liaison, OD.
    Section N-B, Organization and Functions, under the heading Office 
of the Director (NA, formerly HNA), is amended as follows:
    (1) Under the heading Office of Communications and Public Liaison 
(NA8, formerly HNA8) insert the following:
    Office of Community Liaison (NA85, formerly HNA85). (1) Advises the 
NIH Director on policies, programs, and issues involving the NIH and 
the surrounding community; (2) plans and directs activities to promote 
collaboration and cooperation between the NIH and the surrounding 
community; (3) conducts and oversees studies, projects, and evaluations 
designed to address problems, questions, and issues of community 
concern and environmental impact; (4) ensures that NIH activities 
affecting the surrounding community involve community representation at 
all levels of design, review, and implementation; and (5) ensures 
effective communication and collaboration on policy and programs 
involving the surrounding community between the Office of the Director, 
NIH, and operating components of the NIH.
    (2) Delete the Office of Community Liaison (NAP, formerly HNAP) in 
its entirety.
    Delegations of Authority: All delegations and redelegations of 
authority to officers and employees of NIH that were in effect 
immediately prior to the effective date of this amendment and are 
consistent with this amendment shall continue in effect, pending 
further redelegation.

    Dated: November 4, 2005.
Elias A. Zerhouni,
Director, National Institutes of Health.
[FR Doc. 06-144 Filed 1-6-06; 8:45 am]
BILLING CODE 4140-01-M
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.